Category: Antibody Technologies
Antibody Technologies market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Immunohistochemistry
The 2025-2030 World Outlook for Immunohistochemistry This study covers the world outlook for immunohistochemistry across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for colorectal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Biologicals
The 2025-2030 World Outlook for Biologicals This study covers the world outlook for biologicals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2025-2030 World Outlook for Albumin Plasma Protein Therapeutics
The 2025-2030 World Outlook for Albumin Plasma Protein Therapeutics This study covers the world outlook for albumin plasma protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Protein Labeling
The 2025-2030 World Outlook for Protein Labeling This study covers the world outlook for protein labeling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Protein Therapeutics
The 2025-2030 World Outlook for Protein Therapeutics This study covers the world outlook for protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin (IVIg)
The 2025-2030 World Outlook for Intravenous Immunoglobulin (IVIg) This study covers the world outlook for intravenous immunoglobulin (IVIg) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Cancer Immunotherapy Monoclonal Antibodies
The 2025-2030 World Outlook for Cancer Immunotherapy Monoclonal Antibodies This study covers the world outlook for cancer immunotherapy monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibodies for Inflammatory Diseases
The 2025-2030 World Outlook for Monoclonal Antibodies for Inflammatory Diseases This study covers the world outlook for monoclonal antibodies for inflammatory diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for PEGylated Protein Therapeutics
The 2025-2030 World Outlook for PEGylated Protein Therapeutics This study covers the world outlook for PEGylated protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Custom Antibodies
The 2025-2030 World Outlook for Custom Antibodies This study covers the world outlook for custom antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Antibody Library Technologies
The 2025-2030 World Outlook for Antibody Library Technologies This study covers the world outlook for antibody library technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Slide Stainers
The 2025-2030 World Outlook for Slide Stainers This study covers the world outlook for slide stainers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
-
The 2025-2030 World Outlook for Antibodies
The 2025-2030 World Outlook for Antibodies This study covers the world outlook for antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2025-2030 World Outlook for Cell Surface Marking Antibodies
The 2025-2030 World Outlook for Cell Surface Marking Antibodies This study covers the world outlook for cell surface marking antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Inhibitors
The 2025-2030 World Outlook for Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Inhibitors This study covers the world outlook for programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors across more than 190 countries. For each year reported, estimates are given fo ... Read More
-
The 2025-2030 World Outlook for Phage Display Antibody Library Technologies
The 2025-2030 World Outlook for Phage Display Antibody Library Technologies This study covers the world outlook for phage display antibody library technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Antibody Drugs
The 2025-2030 World Outlook for Antibody Drugs This study covers the world outlook for antibody drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
-
The 2025-2030 World Outlook for Research Antibodies and Reagents
The 2025-2030 World Outlook for Research Antibodies and Reagents This study covers the world outlook for research antibodies and reagents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Next-Generation Antibodies
The 2025-2030 World Outlook for Next-Generation Antibodies This study covers the world outlook for next-generation antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Selective Inhibitor of Cytokine Production and Function Organ Transplant Immunosuppressants
The 2025-2030 World Outlook for Selective Inhibitor of Cytokine Production and Function Organ Transplant Immunosuppressants This study covers the world outlook for selective inhibitor of cytokine production and function organ transplant immunosuppressants across more than 190 countries. For each yea ... Read More
-
The 2025-2030 World Outlook for Next Generation Antibody Therapeutics
The 2025-2030 World Outlook for Next Generation Antibody Therapeutics This study covers the world outlook for next generation antibody therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Mammalian Polyclonal IgG Antibodies
The 2025-2030 World Outlook for Mammalian Polyclonal IgG Antibodies This study covers the world outlook for mammalian polyclonal IgG antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Bioengineered Monoclonal Antibodies Protein Drugs
The 2025-2030 World Outlook for Bioengineered Monoclonal Antibodies Protein Drugs This study covers the world outlook for bioengineered monoclonal antibodies protein drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning ... Read More
-
The 2025-2030 World Outlook for Combination Antibody Therapies
The 2025-2030 World Outlook for Combination Antibody Therapies This study covers the world outlook for combination antibody therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
Research Assistance
